Charles Schwab Investment Management Inc Organogenesis Holdings Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 924,776 shares of ORGO stock, worth $2.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
924,776
Previous 910,739
1.54%
Holding current value
$2.64 Million
Previous $2.59 Million
0.12%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding ORGO
# of Institutions
120Shares Held
62.3MCall Options Held
28.8KPut Options Held
27.9K-
Morgan Stanley New York, NY11.6MShares$33.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT11.5MShares$32.9 Million3.27% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$14.5 Million0.0% of portfolio
-
Assenagon Asset Management S.A.3.98MShares$11.4 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$10.2 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $374M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...